The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients
Breast cancer: Circulating cell counts predict chemo response Breast cancer patients do better after preoperative chemotherapy if their numbers of circulating endothelial progenitor cells (CEPs) go up. A team from Japan led by Takayuki Ueno from the Kyorin University School of Medicine in Tokyo stud...
Guardado en:
Autores principales: | Sunao Tanaka, Takayuki Ueno, Hiroshi Ishiguro, Satoshi Morita, Masakazu Toi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7c69591439a41088fdbe1d3155512cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
por: Kunnuru SKR, et al.
Publicado: (2020) -
Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
por: Sunghoon Joo, et al.
Publicado: (2021) -
Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
por: Ana Julia Aguiar de Freitas, et al.
Publicado: (2021) -
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
por: Mark Jesus M. Magbanua, et al.
Publicado: (2021) -
Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.
por: Caroline Schmidt-Lucke, et al.
Publicado: (2010)